C&B Capital
Overview
C&B Capital is the private equity investment arm of Croft & Bender, an investment banking firm, that selectively invests in privately held companies, including emerging growth companies and middle-market opportunities.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Crayon | May 2021 | Series B | Co-investor |
| ChartSpan | Jun 2019 | Series A | Co-investor |
| Cecelia Health | Sep 2018 | VC Round | Co-investor |
For institutional investors. Book with your work email.
Key People
Ed Croft
Managing Director
Kyle Schickner
Managing Director
Matt Veal
Managing Director
Neale Fisher
Managing Director
Lee Anderson
Chief Financial Officer And FINOP
Brad Germany
Vice President
Connor B.
Investment Banking Director
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is C&B Capital based?
C&B Capital is headquartered in Atlanta, Georgia, United States.
When was C&B Capital founded?
C&B Capital was founded in 2000.
How many portfolio companies does C&B Capital have?
C&B Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in C&B Capital's portfolio?
Portfolio companies visible on Caplight include Crayon, ChartSpan, Cecelia Health.
What was C&B Capital's most recent investment shown here?
C&B Capital's most recent investment in this portfolio sample was in Crayon in 2021.
What sectors does C&B Capital focus on?
C&B Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does C&B Capital focus on?
C&B Capital typically invests at the Early stage.
What is C&B Capital's AUM?
C&B Capital's assets under management are estimated at over $82.0M.